Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eric Sartori is active.

Publication


Featured researches published by Eric Sartori.


European Journal of Medicinal Chemistry | 1990

Aldose reductase inhibition by 2,4-oxo and thioxo derivatives of 1,2,3,4-tetrahydroquinazoline

Florence Billon; Chantal Delchambre; Alix Cloarec; Eric Sartori; Jean-Marie Teulon

Abstract Inhibitors of aldose reductase are believed to be useful for the treatment of diabetic complications. Original [(2,4-dioxo-1,2,3,4-tetrahydro)quinazolin-1-yl] acetic acids and their thioxo derivatives have been synthesized and examined for their ability to inhibit aldose reductase in vitro and in vivo . Most were active in vitro on rat lens aldose reductase in the 10 −7 molar range. Compound V 16 , which has a (2′-fluoro-4′-bromo)benzyl substituent on nitrogen N-3 was found in hypergalactosemic rats to be a good inhibitor of galactitol accumulation in sciatic nerves and to prevent cataract formation.


European Journal of Medicinal Chemistry | 1990

Original paperAldose reductase inhibition by 2,4-oxo and thioxo derivatives of 1,2,3,4-tetrahydroquinazolineL'inhibition de l'aldose réductase par des dérivés 2,4-oxo et thioxo de la 1,2,3,4-tétrahydro quinazoline

Florence Billon; Chantal Delchambre; Alix Cloarec; Eric Sartori; Jean-Marie Teulon

Abstract Inhibitors of aldose reductase are believed to be useful for the treatment of diabetic complications. Original [(2,4-dioxo-1,2,3,4-tetrahydro)quinazolin-1-yl] acetic acids and their thioxo derivatives have been synthesized and examined for their ability to inhibit aldose reductase in vitro and in vivo . Most were active in vitro on rat lens aldose reductase in the 10 −7 molar range. Compound V 16 , which has a (2′-fluoro-4′-bromo)benzyl substituent on nitrogen N-3 was found in hypergalactosemic rats to be a good inhibitor of galactitol accumulation in sciatic nerves and to prevent cataract formation.


Archive | 1997

Novel 3,4-diaryloxazolone derivatives, methods of preparation and therapeutic uses thereof

Eric Sartori; Jean-Marie Teulon


Archive | 1997

3,4-diaryloxazolone derivatives, their methods of preparation and their uses in therapeutics

Eric Sartori; Jean-Marie Teulon


Archive | 1997

3,4-diarylthiazolin-2-one or -2-thione derivatives, their methods of preparation and their uses in their methods of preparation and their uses in therapeutics

Eric Sartori; Jean-Marie Teulon


Archive | 1992

Analgesic α-amino-N-pyridylbenzenepropanamide derivatives and pharmaceutical compositions containing them

Nicole Bru-Magniez; Eric Sartori; Jean-Marie Teulon


Archive | 1998

Novel 3,4-diarylthiazolin-2-one or -2-thione derivatives, preparation methods and uses in therapy

Eric Sartori; Jean-Marie Teulon


Archive | 1990

New pyrimidine derivatives which are antagonists of angiotensin-II receptors, processes for their preparation and pharmaceutical compositions containing them

Nicole Bru-Magniez; Jean Lacrampe; Eric Sartori; Jean-Marie Teulon


Archive | 1998

NOUVEAUX DERIVES 3,4-DIARYLTHIAZOLIN-2-ONE OU -2-THIONE, LEURS PROCEDES DE PREPARATION ET LEURS UTILISATIONS EN THERAPEUTIQUE

Eric Sartori; Jean-Marie Teulon


Archive | 1997

Nouveaux derives 3,4-diaryloxazolone, leurs procedes de preparation, et leurs utilisations en therapeutique

Eric Sartori; Jean-Marie Teulon

Collaboration


Dive into the Eric Sartori's collaboration.

Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge